Allergy and immunology billing
Most claims report what happened. An antigen preparation claim reports what was mixed and what was planned. The units are doses, a dose is a milliliter of vial volume rather than a visit or an injection, and the number billed is the number anticipated when the vial was made -- which the Claims Processing Manual says is not to be revised afterwards in either direction, however many injections the patient actually received.
- Antigen preparation and antigen injection are separate services, billed on separate codes
- For the multiple-dose vial code, the billable quantity is volume prepared, capped at ten doses per vial
- The number of doses billed is the number planned at preparation, and is not adjusted later
- The immunotherapy series carries a zero-day global period, so a same-day visit needs modifier 25
This is an educational guide to how billing works for allergy & immunology — its workflow, coding, and payer considerations. It is general information, not a statement that US Medical Billing serves this specialty, and not billing, coding, or legal advice.
What makes allergy and immunology billing distinct
Allergy immunotherapy is one of the few services in medicine where the product and the act of giving it are separately billable, and the code set was deliberately split to make that so. The Claims Processing Manual states that the complete-service codes -- the ones representing both the antigen and its injection -- are not valid for Medicare, and that separate coding for the injection codes and for the codes representing antigens and their preparation must be used. If a practice performs both, it bills both. A practice preparing antigen for someone else to inject bills only the preparation.
The unit on the preparation line is where this specialty stops resembling anything else. The manual explains the arithmetic openly: in setting the practice-expense component for mixing a multiple-dose vial, CMS observed that the most common practice was to prepare a ten-cubic-centimeter vial and the most common use was to remove aliquots of one cubic centimeter, and the payment was computed on those facts. The consequence is stated as a rule -- a physician may not bill the vial preparation code for more than ten doses per vial -- and the manual's own examples make the divergence concrete. Half-milliliter aliquots drawn from a ten-milliliter vial produce twenty injections and may be billed as ten doses. A twenty-milliliter vial drawn off in two-milliliter aliquots produces ten injections and may be billed as twenty doses. The claim is measuring the vial, not the patient.
The second peculiarity is that the quantity is a forecast, and the manual forbids correcting it. Physicians are to specify the number of doses provided, meaning the number prospectively planned when the vial was prepared. If doses are later adjusted because of a patient reaction and the vial yields more or fewer than anticipated, the manual instructs that no change is to be made to the billing -- contractors are not to pay more where the vial went further, and not to seek recoupment where it went less. Almost every other quantity in medical billing is a claim about something that happened. This one is a claim about something that was scheduled, left deliberately unreconciled.
A third rule turns a payment policy into a preparation practice. Venom antigens are prepared in separate vials, and the codes are priced with savings built into the higher venom counts, so contractors are directed to pay at the highest venom level possible. When dose adjustment desynchronizes a multi-venom regimen -- one vial lasting longer than the other -- the manual instructs physicians to prepare replacement antigen in a way that resynchronizes back to the highest venom code as soon as possible, and says that using a lower venom code should occur only for the purpose of catching up. The pharmacy bench is being told how to mix by a payment rule.
Coverage of the antigen itself has its own conditions, and they are unusually personal. Payment may be made for a reasonable supply of antigens prepared for a particular patient only where the antigens were prepared by a doctor of medicine or osteopathy who has examined that patient and determined a plan of treatment and a dosage regimen. The manual sets a reasonable supply at not more than a twelve-month supply prepared at any one time, and gives the reason: potency over the period across which the doses will be given. Administration may be by the physician or by a properly instructed person under supervision -- who, the manual says, could be the patient.
How allergy and immunology billing flows
Testing, preparation and administration are three separate billing events on three different clocks, and only one of them is a visit.
Testing, counted as tests
Allergy testing fee amounts are established for a single test, so the number of tests performed is the quantity on the claim -- twenty-five percutaneous tests are one code with twenty-five units, and the contractor multiplies the single-test amount by the units field.
Common operational challenges
Nearly all of these come from a quantity that is created in the preparation room and used in the billing office months later.
A quantity nobody in billing can observe
The billable dose count is decided when the vial is mixed, by the person mixing it. If the planned dose count and the vial volume do not travel from the bench to the claim, the units become an estimate made by someone who was not there.
Injections and doses that do not reconcile
A patient can receive twenty injections from a vial billed as ten doses, or ten injections from a vial billed as twenty. Any reconciliation built on the assumption that one injection equals one billed dose will report a problem that does not exist.
A forecast that must not be corrected
When a reaction changes the dosing schedule, the instinct is to adjust the claim. The manual says not to, in both directions. Practices with a strong corrections culture have to carve out an explicit exception here.
Two services, months apart, on one course of care
Preparation is claimed once and injections are claimed across a long series of short visits. Following whether a course was paid correctly means joining lines that are not on the same claim, the same date, or sometimes the same year.
Documentation and coding considerations
The notes below describe payment and reporting rules from the Medicare manuals; they do not reproduce any code descriptions.
Preparation and injection are reported separately
The Claims Processing Manual states that the complete-service codes representing both the antigen and its injection are not valid for Medicare, and that separate coding for the injection codes and for the antigen preparation codes must be used. Where both services are provided, both codes are billed.
A dose is a milliliter of vial volume
The practice-expense computation for the multiple-dose vial code assumes a ten-cubic-centimeter vial drawn off in one-cubic-centimeter aliquots, so no more than ten doses may be billed per multiple-dose vial regardless of how many aliquots are actually removed. A vial holding less than that is billed for the number of one-milliliter aliquots it can yield.
The count is the plan, not the outcome
Physicians specify the number of doses anticipated at the time of preparation. Where dose amounts are later adjusted and the vial yields more or fewer doses, the manual instructs that no change be made to the billing -- and that contractors neither pay more nor pursue recoupment on that basis.
Single-dose vials billed alongside an injection
The manual directs contractors to convert a single-dose vial preparation code to the multiple-dose vial code and pay accordingly when it is billed together with an injection code, on the reasoning that a practice preparing and administering its own antigen can draw proper doses from the less costly multiple-dose vial.
A zero-day global period, applied on purpose
CMS changed the global surgery indicator for the allergen immunotherapy series so that the global surgery concept applies with no postoperative days. The stated effect is that modifier 25 became the only route by which a visit on the same day as an immunotherapy service can be paid.
Denial and rejection risks
Two of these are overpayments rather than denials, which makes them the ones a practice finds last.
More doses billed than the vial supports
Billing a multiple-dose vial for the number of injections drawn from it rather than for its volume overpays the practice expense the code was priced on. The manual states the cap and explains why it exists, which makes exceeding it difficult to characterize as an interpretation.
A revised dose count after an adjustment
Rebilling to match what the vial actually yielded contradicts an explicit instruction. Where it results in additional payment it is an overpayment; where it results in less it is revenue given away for no reason.
A same-day visit without modifier 25
Since the immunotherapy series took a global surgery indicator, a visit reported alongside it without the modifier is not separately payable. The record must show work beyond the immunotherapy service, not merely that the patient was seen.
Potency testing billed before an injection
The NCCI Policy Manual states that confirming the appropriate potency of an allergen vial is an inherent component of immunotherapy, and that allergy testing codes are not to be reported for potency or safety testing before administration.
Testing and immunotherapy on the same day
The manual notes these are generally not reported on the same date, since testing precedes immunotherapy in standard practice -- the exception being genuine testing for additional allergens on a day immunotherapy is also given.
Payer-process considerations
The federal rules describe Original Medicare. What varies most between payers here is the unit, which is the worst thing to vary.
Coverage attaches to a named patient
Payment for a supply of antigens depends on the preparing physician having examined that patient and determined a plan of treatment and dosage regimen. Antigen prepared without that examination behind it is outside the benefit rather than under-documented.
A supply limit set by potency
The manual treats a reasonable supply as not more than a twelve-month supply prepared for a particular patient at any one time, and gives potency over the administration period as the reason. It is a clinical rationale expressed as a payment condition.
Who may administer, and where
Antigens must be administered in accordance with the plan of treatment by a doctor of medicine or osteopathy or by a properly instructed person under supervision -- who, the manual says, could be the patient. That widens where doses are given without widening who may bill for them.
Commercial definitions of a dose vary
The volume-based dose is Medicare's construction, tied to how it priced practice expense. Commercial plans and Medicare Advantage plans may count doses differently, cap vials differently or require authorization, so the same vial can be billed two ways for two patients.
Revenue-cycle checkpoints
The first three all concern one number, because that number is this specialty's whole revenue risk.
- Capture vial volume, vial count and the planned dose count at preparation, and carry them to the claim
- Bill preparation by volume, never by the number of injections drawn from the vial
- Leave the dose count unchanged when a reaction alters the schedule, in both directions
- Bill preparation and injection as separate services, and never use a complete-service code
- Confirm the preparing physician examined the patient and set a plan of treatment and dosage regimen
- Keep prepared supply within a reasonable supply for one patient at one time
- Apply modifier 25 only where the same-day visit went beyond the immunotherapy service
- Plan venom replacement preparation so the regimen returns to the highest applicable venom code quickly
Related & connected
Services, tools, background reading and definitions that connect to the allergy and immunology revenue-cycle steps above.
Related services
Calculators & tools
- Modifier 25 and 59 documentation checklistCheck whether the record supports a same-day visit before the claim goes out.
- Professional claim release checklistWhat to confirm before a professional claim goes out, including the quantity fields.
- Contractual variance calculatorCompare expected against paid, which is how a units error on a preparation line surfaces.
From the Knowledge Base
- Claim-level and line-level informationWhere units live on a claim, and why the quantity field carries the meaning here.
- Modifier 25 documentationWhat a significant, separately identifiable visit has to show beyond the procedure.
- Medicare fee schedules explainedHow practice expense is built into a payment amount -- which is where the ten-dose cap comes from.
- Underpayments and overpaymentsFinding a claim that paid for the wrong quantity, in either direction, after the fact.
Glossary
- Claim lineThe row whose units field, on a preparation claim, describes a vial rather than a patient.
- Modifier 25The significant, separately identifiable visit billed on the same day as another service.
- Global periodThe window this code family was given specifically so a same-day visit could be controlled.
- Fee scheduleThe published amounts whose practice-expense component sets the cap on doses per vial.
Frequently asked questions
What counts as a dose on an antigen preparation claim?
A milliliter of vial volume, not an injection. The Claims Processing Manual explains that when CMS set the practice-expense component for mixing a multiple-dose vial, it observed that the most common practice was a ten-cubic-centimeter vial and the most common use was removing one-cubic-centimeter aliquots, and computed payment on that basis. The rule that follows is that a physician may not bill the vial preparation code for more than ten doses per vial. The manual's own examples run both ways: half-milliliter aliquots giving twenty injections from a ten-milliliter vial may be billed as ten doses, and a twenty-milliliter vial drawn off in two-milliliter aliquots may be billed as twenty doses even though only ten injections come out of it.
If the patient's dosing changes, should the number of doses billed be corrected?
No, and the manual addresses this directly. Physicians bill the number of doses anticipated at the time the antigen was prepared. Where doses are later adjusted -- because of a patient reaction, for instance -- and the vial turns out to hold more or fewer doses than planned, no change is to be made to the billing. Contractors are instructed not to pay more where the vial went further, and not to seek recoupment where it did not go as far. The quantity is a record of what was scheduled when the vial was provided.
Why are the antigen and the injection billed on separate codes?
Because Medicare does not accept the combined ones. The manual states that the complete-service codes, which include both the injection service and the antigen and its preparation, are not valid for Medicare, and that separate coding must be used for the injection codes and for the antigen preparation codes. A practice that performs both bills both. A practice that prepares antigen for another entity to inject bills only preparation -- and the manual notes that where a single-dose vial preparation code is billed together with an injection code, the contractor converts it to the multiple-dose vial code and pays at that rate.
Can an office visit be billed on an injection day?
Only where it was genuinely separate, and the mechanism is deliberate. Effective for services from January 1995, CMS applied global surgery policy to the allergen immunotherapy series by changing its global surgery indicator so that the concept applies with no days in the postoperative period. The manual states that this makes modifier 25 the only means by which a visit provided on the same day as an immunotherapy service can be paid, and that the modifier asserts the patient's condition required a significant, separately identifiable visit above and beyond the immunotherapy service.
How much antigen may be prepared at once?
The Benefit Policy Manual treats a reasonable supply as not more than a twelve-month supply prepared for a particular patient at any one time, and states the reason plainly: to assure the antigens retain potency and effectiveness across the period over which they will be administered. Coverage also depends on the antigens having been prepared by a doctor of medicine or osteopathy who examined that patient and determined a plan of treatment and a dosage regimen, and on administration following that plan -- by the physician or by a properly instructed person under supervision, who the manual notes could be the patient.
Sources
Last reviewed August 1, 2026.
- Centers for Medicare & Medicaid Services (CMS)Medicare Claims Processing Manual (Pub. 100-04), Chapter 12 §200 Allergy Testing and Immunotherapy -- testing billed as a number of single tests; the complete-service codes being invalid for Medicare and preparation and injection reported separately; the conversion of a single-dose vial code billed with an injection; doses billed as the number prospectively planned with no later adjustment in either direction; venom dose synchronization and catch-up billing; the practice-expense derivation of the ten-dose-per-vial cap with its worked examples; and the change of the immunotherapy global surgery indicator making modifier 25 the route to a same-day visit
- Centers for Medicare & Medicaid Services (CMS)Medicare Benefit Policy Manual (Pub. 100-02), Chapter 15 §50.4.4.1 Antigens -- payment for a reasonable supply of antigens prepared for a particular patient, the requirement that the preparing physician examined the patient and determined a plan of treatment and dosage regimen, administration by a physician or a properly instructed person under supervision, and the twelve-month reasonable-supply limit with its potency rationale
- Centers for Medicare & Medicaid Services (CMS)National Correct Coding Initiative Policy Manual, Chapter XI (Medicine) sections K and M -- the division of allergy services into testing and immunotherapy with separate antigen preparation and administration codes; the unit of service for testing being the number of separate tests; potency confirmation as an inherent component of immunotherapy; informed consent included in the immunotherapy service; testing as an integral part of rapid desensitization; and the definition of a dose as one milliliter for antigen preparation reporting
Ready to improve your revenue cycle?
Tell us about your practice and we’ll tell you where we would start.